14-75902201-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_015072.5(TTLL5):āc.3800T>Cā(p.Phe1267Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.224 in 1,613,720 control chromosomes in the GnomAD database, including 50,283 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_015072.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TTLL5 | NM_015072.5 | c.3800T>C | p.Phe1267Ser | missense_variant | 31/32 | ENST00000298832.14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TTLL5 | ENST00000298832.14 | c.3800T>C | p.Phe1267Ser | missense_variant | 31/32 | 1 | NM_015072.5 | P4 |
Frequencies
GnomAD3 genomes AF: 0.309 AC: 46873AN: 151924Hom.: 9126 Cov.: 32
GnomAD3 exomes AF: 0.282 AC: 70728AN: 250988Hom.: 12395 AF XY: 0.278 AC XY: 37641AN XY: 135632
GnomAD4 exome AF: 0.215 AC: 314666AN: 1461678Hom.: 41127 Cov.: 33 AF XY: 0.219 AC XY: 159376AN XY: 727154
GnomAD4 genome AF: 0.309 AC: 46964AN: 152042Hom.: 9156 Cov.: 32 AF XY: 0.311 AC XY: 23085AN XY: 74340
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 14, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at